FdaApplication
NDA 217171
Identifiers
- fda_app_no: NDA217171
Properties
| Property | Value |
|---|---|
| applicant_name | APELLIS PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2023-02-17 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SYFOVRE | PEGCETACOPLAN | 15MG/0.1ML (15MG/0.1ML) | SOLUTION;INTRAVITREAL |
1 product